Vertex Pharmaceuticals
VRTX
#134
Rank
โ‚ฌ113.89 B
Marketcap
442,26ย โ‚ฌ
Share price
-3.77%
Change (1 day)
39.95%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ6.27 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ6.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ4.65 B17.91%
2022-12-31โ‚ฌ3.95 B34.27%
2021-12-31โ‚ฌ2.94 B18.09%
2020-12-31โ‚ฌ2.49 B25%
2019-12-31โ‚ฌ1.99 B25.95%
2018-12-31โ‚ฌ1.58 B26.29%
2017-12-31โ‚ฌ1.25 B-15.42%
2016-12-31โ‚ฌ1.48 B15.32%
2015-12-31โ‚ฌ1.28 B26.18%
2014-12-31โ‚ฌ1.01 B46.09%
2013-12-31โ‚ฌ0.69 B-41.02%
2012-12-31โ‚ฌ1.18 B20.31%
2011-12-31โ‚ฌ0.98 B6.98%
2010-12-31โ‚ฌ0.91 B53.14%
2009-12-31โ‚ฌ0.59 B13.04%
2008-12-31โ‚ฌ0.53 B134.58%
2007-12-31โ‚ฌ0.22 B-28.21%
2006-12-31โ‚ฌ0.31 B20.44%
2005-12-31โ‚ฌ0.26 B-30.44%
2004-12-31โ‚ฌ0.37 B-10.95%
2003-12-31โ‚ฌ0.42 B0.97%
2002-12-31โ‚ฌ0.41 B-17.89%
2001-12-31โ‚ฌ0.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ33.60 B 435.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ130.43 B 1,978.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ69.29 B 1,004.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.62 B 1,057.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ102.68 B 1,536.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.23 B-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA